Literature DB >> 12759456

P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release.

Philip A Verhoef1, Mark Estacion, William Schilling, George R Dubyak.   

Abstract

In response to ATP binding, the P2X7R facilitates cation channel activation, nonspecific pore formation, rapid changes in plasma membrane morphology, and secretion of IL-1 beta from LPS-primed macrophages. To investigate the relationship between the P2X7R-dependent changes in plasma membrane organization and the release of IL-1 beta, we generated time-lapse movies of ATP-stimulated BAC1 murine macrophages in conjunction with biochemical analyses of IL-1 beta release. Similar image analyses in human embryonic kidney 293 cells expressing recombinant P2X7R (HEK-P2X7) permitted comparison of P2X7R-dependent effects in macrophage vs nonmacrophage backgrounds. Whereas HEK-P2X7 cells exhibit zeiotic blebbing within 5 min of ATP treatment, BAC1 macrophages initiated a distinct "tethered" blebbing 10 min after ATP addition. This blebbing was comparably induced by the P2X7R-selective agonist BzATP and was blocked by P2X7R inhibitors KN-62 and oxidized ATP. Blebbing was initiated at ATP concentrations > or = 3 mM, but optimal IL-1 beta release occurred at 1 mM ATP. P2X7R-dependent blebbing was abrogated in the presence of Rho-effector kinase inhibitors Fasudil and Y-27632, but ATP-induced IL-1 beta release was unaffected. ATP-induced activation of RhoA could be detected in both HEK-P2X7 cells and BAC1 murine macrophages. Thus, P2X7R activation signals distinct, novel membrane blebbing events (dependent on RhoA activation and Rho-effector kinase activity) and simultaneously initiates release of IL-1 beta. Our observations that blebbing and IL-1 beta release are dissociable suggest these events occur via parallel rather than convergent signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759456     DOI: 10.4049/jimmunol.170.11.5728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.

Authors:  Cristina Andrei; Paola Margiocco; Alessandro Poggi; Lavinia V Lotti; M R Torrisi; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 2.  IL-1beta: an endosomal exit.

Authors:  Mark D Wewers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

3.  C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation.

Authors:  Sébastien Roger; Ludovic Gillet; Alberto Baroja-Mazo; Annmarie Surprenant; Pablo Pelegrin
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

4.  Identification of Thr283 as a key determinant of P2X7 receptor function.

Authors:  M T Young; P Pelegrin; A Surprenant
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

Review 5.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

6.  The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol.

Authors:  Britta Blumenthal; Claudia Hoffmann; Klaus Aktories; Steffen Backert; Gudula Schmidt
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

7.  Dynamic redistribution of paxillin in bovine osteoblasts stimulated with adenosine 5'-triphosphate.

Authors:  Ann-Sophie Silber; Bastian Pfau; Toh Weng Tan; Ralf Jacob; David Jones; Thomas Meyer
Journal:  J Mol Histol       Date:  2012-05-05       Impact factor: 2.611

Review 8.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

9.  Reanalysis of P2X7 receptor expression in rodent brain.

Authors:  Joan A Sim; Mark T Young; Hye-Youn Sung; R Alan North; Annmarie Surprenant
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

10.  Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.

Authors:  Chengqun Sun; Jessica Chu; Sarita Singh; Russell D Salter
Journal:  Purinergic Signal       Date:  2009-10-17       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.